TeraRecon Cardiovascular.Calcification.CT vs Stethee Pro 1
AI Verdict
Choose TeraRecon Cardiovascular.Calcification.CT if…
Choose TeraRecon Cardiovascular.Calcification.CT if your primary need is automated, quantitative analysis of coronary artery calcification from CT images. This tool is ideal for radiologists and cardiologists requiring precise 3D segmentation, Agatston scores, and detailed plaque measurements to inform cardiovascular risk assessment and treatment strategies. It excels in providing in-depth insights from existing imaging data.
View TeraRecon Cardiovascular.Calcification.CT →Choose Stethee Pro 1 if…
Choose Stethee Pro 1 if you require a portable, AI-enabled digital stethoscope for real-time cardiac and respiratory vital sign analysis and auscultation. This system is best suited for clinicians in telemedicine, remote monitoring, or emergency settings who need immediate, amplified sound data, visualization, and secure sharing of heart and lung sounds for rapid diagnostic support. It provides on-the-go physiological assessment.
View Stethee Pro 1 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | TeraRecon Cardiovascular.Calcification.CT | Stethee Pro 1 |
|---|---|---|
| Pricing | Unknown | $499 usd |
| Deployment | Cloud-enabled imaging platform. | Cloud, Mobile |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Stethee Pro 1While Tool A offers automated image analysis within existing workflows, Tool B emphasizes a 'simple to use, beautifully designed' device with an intuitive mobile and web application that significantly reduces the time for vital sign capture compared to traditional methods. Its real-time, interactive nature and ease of data sharing directly at the point of care give it an edge in immediate usability for clinicians.
Clinical Value
TeraRecon Cardiovascular.Calcification.CTTool A provides comprehensive, quantitative imaging analysis for cardiovascular risk assessment and surgical planning, delivering actionable data for long-term patient management. In contrast, while Tool B boasts innovative real-time diagnostic capabilities, its current unavailability for commercial distribution significantly limits its practical clinical value.
Pricing & Value
TeraRecon Cardiovascular.Calcification.CTTool A offers a transparent, subscription-based annual fee model, providing predictable budgeting and eliminating renewal complexities for enterprise clients. While Tool B has a clear upfront device cost, its current unavailability for commercial distribution means its stated pricing and value cannot be realized in practice.
Enterprise Readiness
TeraRecon Cardiovascular.Calcification.CTTool A explicitly states BAA availability, HIPAA compliance, and FDA clearance, and offers robust enterprise deployment options (containerized, SaaS cloud) with integration into existing clinical platforms and automatic updates for compliance. While Tool B also claims HIPAA compliance and FDA clearance, its current lack of commercial availability makes it not ready for enterprise adoption.
Innovation
Stethee Pro 1Tool B is explicitly marketed as 'The World's First AI-Enabled Wireless Stethoscope System,' integrating AI with a physical device for real-time cardiac and respiratory analysis, including unique features like geo-location and environmental data tagging. This represents a more disruptive innovation in a traditional medical device category compared to Tool A's advanced, but more incremental, automation of image analysis.
Support & Docs
TeraRecon Cardiovascular.Calcification.CTTeraRecon provides comprehensive and globally accessible support services, including technical support, training, and readily available user manuals, with clear contact channels and a 24-hour emergency line. While M3DICINE offers a support section, the current unavailability of Stethee Pro 1 for commercial distribution means its support infrastructure is not fully operational for active users.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | TeraRecon Cardiovascular.Calcification.CT | Stethee Pro 1 |
|---|---|---|
| Product Name | TeraRecon Cardiovascular.Calcification.CT | Stethee Pro 1 |
| Company | Terarecon | M3DICINE Pty Ltd. |
| Primary Function | AI-powered software as a medical device (SaMD) that analyzes CT images to automatically detect and measure calcifications in the coronary arteries. | FDA-cleared, AI-enabled wireless digital stethoscope system providing real-time cardiac and respiratory vital sign analysis, advanced amplification, and secure data sharing. |
| Key Output/Analysis | Automatic 3D segmentation of calcified plaques in coronary arteries; Outputs mask for calcium scoring systems; Supports Agatston score, volume, mean mass (mg) measurements. | Captures cardiac and respiratory vital signs in 20 seconds; Measures systole, diastole, heart cycle durations, and respiration rate; Real-time visualization of heart (PCG, AIDA Cycle, AIDA Energy) and lung sounds (spectrogram). |
| Target Specialties | Cardiology, Cardiothoracic Surgery, Radiology | Cardiology, Emergency Medicine, Pulmonology |
Videos
Demos, reviews, and walkthroughs featuring TeraRecon Cardiovascular.Calcification.CT and Stethee Pro 1.